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Cancers of the biliary tract encompass tumours arising from the
gallbladder, extrahepatic bile ducts and ampulla of Vater. Although
the aetiology of biliary tract cancers is poorly understood, an
excess risk has been associated with a history of gallstone disease,
especially in relation to gallbladder cancer (Lowenfels et al, 1985;
Maringhini et al, 1987; Fraumeni et al, 1996). The effects of gall-
stones on the risk of liver and pancreas cancers, however, are
unclear (Ichimiya et al, 1986; Maringhini et al, 1987; Cuzick and
Babiker, 1989; Bueno de Mesquita et al, 1992; Kalapothaki et al,
1993; Ekbom et al, 1993). In a recent population-based cohort
study of Swedish patients hospitalized for cholecystectomy,
mostly for gallstones, the subsequent risk of extrahepatic bile duct
cancer was reduced whereas the risks of periampullar and
pancreatic cancers were elevated (Ekbom et al, 1993, 1996). In a
previous population-based cohort study of Danish patients hospi-
talized for gallstones, significant excess risks were observed for
cancers of the liver/biliary tract and pancreas, with the risk
for pancreas cancer being greater among those treated with
cholecystectomy than among non-surgical patients (Johansen
et al, 1996). To pursue these findings, we examined the risk
of cancers of the liver, biliary tract subsites and pancreas in
an expanded nationwide population-based cohort study of
Danish patients hospitalized for gallstones, stratified by cholecys-
tectomy status.
MATERIALS AND METHODS
The data sources for this study have been described in detail previ-
ously (Johansen et al, 1996). The current study extended the
follow-up for cancer through 1993 and used a broader cohort
selection criterion to include gallstone patients with concomitant
conditions such as bile duct stones, inflammation and perforation
within the biliary tract. The National Registry of Patients main-
tains records of over 99% of hospital discharges for somatic
diseases in Denmark (Danish National Board of Health, 1981).
Each discharge record contained a personal identification number
unique to each Danish citizen, date of discharge and up to 20 diag-
noses, classified according to a Danish modification of the
International Classification of Diseases, eighth revision (ICD-8).
In addition, surgical procedures were recorded and classified
according to the Danish Classification of Surgical Procedures and
Therapies (Danish National Board of Health, 1986).
All discharge records with a diagnosis of cholelithiasis (ICD-8
574.00-09) from 1977 to 1989 were extracted. For patients with
multiple hospital discharges for gallstones, the date of the first
hospital discharge was used as the date of entry into the cohort.
Using the personal identification number, linkage was made to the
Danish National Board of Health to obtain information on vital
status and to the Danish Cancer Registry for information on inci-
dent cancers (Storm et al, 1992). Of 64 420 patients initially iden-
tified from the Danish National Registry of Patients, 4244 (6.6%)
were excluded because of death during the first year of follow-up,
leaving 60 176 patients for the study. Patients were followed up for
cancer occurrence until the date of death or the end of 1993,
whichever came first. To minimize selection bias, cancer diag-
noses and person—years accumulated during the first year of
follow-up were excluded from analysis.
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Among the cohort members, 42 461 (65.9%) were treated by
cholecystectomy, 96% of operations being performed within 6
months of the index hospitalization for gallstones. Analyses were
conducted for the entire cohort, and with stratification by chole-
cystectomy status. Person—years and cancer incidence before
cholecystectomy were classified with the non-cholecystectomy
stratum, and person—years for the cholecystectomy stratum were
accumulated following the surgery. Within the cholecystectomy
subcohort, further analyses were conducted to examine whether
risks varied with or without accompanying bile duct surgery,
which may affect risk by associated bile duct stones or subsequent
alterations in bile flow. Furthermore, to assess whether risks
were confounded by other conditions associated with gallstone
disease and the cancer outcomes of interest, additional
analyses were conducted with stratification by obesity and by
selected hepatic diseases, including hepatitis, cirrhosis, haemo-
chromatosis and alcoholism, as discharge diagnoses during any
hospital visit.
The expected numbers of cancers were calculated by multiplying
the number of person—years in the cohort by the national cancer inci-
dence rates for each stratum by sex and age in 5-year groups.
Standardized incidence ratios (SIRs), the ratio of observed to
expected cancer cases and corresponding 95% confidence intervals
(CIs) were computed for 1—4 and ‡5 years intervals following
hospital discharge for gallstones. Tests of significance for the SIR
were based on the assumption that the observed number of a specific
cancer followed a Poisson distribution, with a mean value equal to
the expected number derived from the general population (Bailar
and Ederer, 1964). In addition, to assess the potential for surveillance
bias, SIRs were computed after excluding patients whose cancer of
interest was diagnosed incidentally during autopsy from both the
observed number as well as from the population rates used in calcu-
lating the expected number. Biliary tract cancer risk was evaluated
by anatomical subsite, including the gallbladder, extrahepatic bile
ducts and ampulla of Vater. For comparison, SIRs were computed
for cancers arising from adjacent sites, i.e. the liver and pancreas.
Table 1 Standardized incidence ratios (SIRs) and 95% confidence intervals (CIs) of cancers of liver, biliary tract, and pancreas among gallstone patients by
cholecystectomy status
Never/before After
cholecystectomy cholecystectomya Combined cohort
Number of subjects 17 715 42 461 60 176
Average age at entry 70 56 61
Average years at follow-up 6.1 9.2 8.3
Person-years 109 803 361 648 471 450
Type of cancer #OBS SIRb CI #OBS SIRb CI #OBS SIRb CI
Liver 34 1.9 1.3–2.6 48 1.2 0.9–1.7 82 1.4 1.2–1.8
Gallbladder 42 3.6 2.6–4.9 – – – 42 3.6 2.6–4.9
Extrahepatic bile duct 12 1.5 0.8–2.7 16 1.0 0.6–1.6 28 1.2 0.8–1.7
Ampulla of Vater 8 2.3 1.0–4.5 14 2.0 1.1–3.3 16 2.1 1.3–3.1
Pancreas 80 1.3 1.0–1.6 184 1.4 1.2–1.7 264 1.4 1.2–1.6
aPerson–years (2308) and cancers (7) for these patients prior to their cholecystectomy were allocated to the never/before cholecystectomy stratum. bAdjusted
for age and gender.
Table 2 Standardized incidence ratios (SIRs) and 95% confidence intervals (CIs) of cancers of liver, biliary tract, and pancreas among gallstone patients by
cholecystectomy status and years of follow-up
Years of follow-up
1–4 years 5+ years
#OBS SIRa 95% CI #OBS SIRa 95% CI
Never/before cholecystectomy
Liver 14 1.7 0.9–2.8 20 2.0 1.2–3.1
Gallbladder 26 4.6 3.0–6.7 16 2.7 1.5–4.4
Extrahepatic bile duct 7 2.0 0.8–4.1 5 1.1 0.4–2.7
Ampulla of Vater 6 3.9 1.4–8.4 2 1.0 0.1–3.6
Pancreas 45 1.6 1.2–2.2 35 1.1 0.7–1.5
After cholecystectomyb
Liver 20 1.6 1.0–2.5 28 1.1 0.7–1.5
Extrahepatic bile duct 8 1.6 0.7–3.2 8 0.7 0.3–1.4
Ampulla of Vater 4 1.9 0.5–4.8 10 2.0 1.0–3.7
Pancreas 72 1.8 1.4–2.2 112 1.3 1.1–1.6
aAdjusted for age and gender. bPerson–years for this stratum were accumulated after the cholecystectomy which might be subsequent to cohort entry.642 WH Chow et al
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RESULTS
A total of 471 450 person—years of follow-up were accrued, with
109 803 person—years allocated in the non-cholecystectomy
stratum and 361 648 in the cholecystectomy stratum (Table 1). The
non-cholecystectomy group was much older at cohort entry than
the cholecystectomy group (mean age 70 vs 56 years). There were
generally more women than men, with a female-to-male ratio of
2.1 in the non-cholecystectomy group and 2.8 in the cholecys-
tectomy group. Among those without cholecystectomy, the mean
duration of follow-up was 6.1 years after cohort entry versus 9.2
years following cholecystectomy.
Overall, the risks for liver and extrahepatic bile duct tumours
tended to be higher in the non-cholecystectomy than the cholecys-
tectomy group, although these differences were not statistically
significant (Table 1). Risk estimates for the non-cholecystectomy
stratum were essentially unaltered when person—years (2308) and
cancers (7) for patients who subsequently had cholecystectomy
were excluded (data not shown).
In the non-cholecystectomy group, the risks for cancers of liver
and gallbladder remained significantly elevated at 5 or more years
of follow-up (SIR = 2.0 and 2.7 respectively), as shown in Table 2.
In contrast, the risks for cancers of extrahepatic bile duct, ampulla
of Vater and pancreas declined to near unity at 5 or more years of
follow-up.
On the other hand, in the cholecystectomy group, the risks for
cancers of liver and extrahepatic bile duct cancers dropped to 1.1
and 0.7, respectively, at 5 or more years of follow-up. In contrast, the
risks for cancers of ampulla of Vater and pancreas remained elevated
(SIR = 2.0 and 1.3 respectively), with the excess of pancreas cancer
being statistically significant throughout follow-up.
In the cholecystectomy stratum, the risks for cancers of extra-
hepatic bile duct and ampulla of Vater were similar among patients
who had cholecystectomy only and those who had bile duct surgery
along with cholecystectomy (Table 3). However, the risk for liver
cancer was higher among patients with cholecystectomy only than
among those who also had bile duct surgery, whereas the risk for
pancreas cancer was higher among those with accompanying bile
duct surgery than among those with cholecystectomy only.
The cancer risks (except for liver cancer) were essentially unal-
tered when the analyses were restricted to patients who never had a
hospital discharge diagnosis of obesity or hepatic diseases (Table 3).
For liver cancer, however, the risks were near unity among those
without a history of hepatic conditions and were increased substan-
tially among those with such a history. The results were similar
regardless of cholecystectomy status (data not shown). The numbers
of biliary tract cancers among patients with a diagnosis of obesity or
hepatic conditions were too small for meaningful analysis, whereas
the risk for pancreas cancer was increased twofold.
Exclusion of cancer cases diagnosed incidentally during
autopsy did not appreciably alter the associations seen for cancers
of gallbladder, extrahepatic bile duct, ampulla of Vater and
pancreas (Table 3). The risk of liver cancer, however, was reduced
to 1.2 among those without cholecystectomy, but remained slightly
elevated at 1.4 among those treated with cholecystectomy.
DISCUSSION
Our findings among gallstone patients without cholecystectomy
are consistent with previous reports indicating that gallstone
disease predisposes to biliary tract cancers, particularly gall-
bladder cancer (Lowenfels et al, 1985; Maringhini et al, 1987; Yen
et al, 1987; Chow et al, 1994; Fraumeni et al, 1996). Although the
risk for gallbladder cancer remained elevated at 5 or more years
after hospitalization for gallstone disease, the risks for cancers of
extrahepatic bile duct and ampulla of Vater dropped to near unity,
suggesting that residual selection bias associated with the detec-
tion of existing tumours during the early years of follow-up
contributed to the overall excess of bile duct and ampullary
tumours. The risk for extrahepatic bile duct cancers tended to be
lower among patients with cholecystectomy than among those not
treated surgically, with risk dropping to below unity at 5 or more
years of follow-up. This finding is consistent with an earlier
Swedish cohort study of cholecystectomy patients indicating a
significantly lowered risk of extrahepatic bile duct cancer after
long-term follow-up (Ekbom et al, 1993).
Also consistent with the recent Swedish study (Ekbom et al,
1996), patients in our cholecystectomy group had significantly
Table 3 Standardized incidence ratios (SIRs) of cancers of liver, biliary tract and pancreas among gallstone patients with stratification by cohort characteristics
Extrahepatic Ampulla
Liver Gallbladder bile duct of Vater Pancreas
Stratification variable #OBS SIR #OBS SIR #OBS SIR #OBS SIR #OBS SIR
Bile duct surgerya
No (PYb = 282 195) 39 1.5c NAd – 11 1.0 10 2.0 110 1.2c
Yes (PY = 79 453) 9 0.8 NA – 5 1.0 4 1.8 74 1.9c
Obesity
No (PY = 447 911) 77 1.4c 39 3.6c 28 1.2 19 1.9c 245 1.4c
Yes (PY = 23 539) 5 2.1 3 3.6 0 0.0 3 6.5c 19 2.2c
Hepatic diseasese
No (PY = 455 253) 53 1.0 40 3.5c 27 1.2 20 1.9c 252 1.4c
Yes (PY = 16 197) 29 15.0c 2 6.0 1 1.4 2 6.2 12 2.0c
Excluded autopsy
Never/before cholecystectomy 17 1.2 37 3.7c 12 1.6 4 1.2 70 1.3
After cholecystectomy 42 1.4 NA – 16 1.0 14 2.1c 168 1.4c
aCholecystectomy with accompanying bile duct surgery; excluded non-surgical patients. bPerson–years. cP < 0.05. dNot applicable. eIncluded hepatitis, cirrhosis,
haemochromatosis and alcoholism.elevated risks for cancers of ampulla of Vater and pancreas that
persisted after 5 or more years of follow-up, although the long-
term excess of pancreatic cancer was small. While selection bias,
small numbers and chance variation may partly explain this
finding, it seems plausible that cholecystectomy rather than gall-
stone formation is the more important risk factor for cancers of
ampulla of Vater and perhaps pancreas. In laboratory animals,
cholecystectomy has been shown to stimulate pancreatic hyper-
trophy and hyperplasia (Rosenberg et al, 1984) and predispose to
benign and malignant tumours of the pancreas (Ura et al, 1986;
Watanapa and Williamson, 1993). Although the mechanism of
action is unclear, it has been suggested that cholecystectomy
increases circulating levels of cholecystokinin—pancreozymin, a
gastrointestinal hormone with trophic effects on the pancreas
(Watanapa and Williamson, 1993; Anderson et al, 1996).
The elevated risk of liver cancer among patients without chole-
cystectomy may be explained, in part, by increased surveillance,
as exclusion of cases diagnosed incidentally at autopsy reduced the
risk to near unity. In addition, the risk of liver cancer was reduced
to unity among cohort members who were not previously hospital-
ized for hepatic diseases, suggesting that gallstone disease without
hepatic complications is not an important risk factor for liver
cancer. As gallstones and other extrahepatic diseases may increase
inflammatory mediators such as cytokine expression in the liver
(Fukuma et al, 1996), however, further assessment of the risk of
liver cancer among gallstone patients may be warranted.
While obesity is a well-established risk factor for gallbladder
cancer (Fraumeni et al, 1996) and may also be linked to cancers of
liver and pancreas (Moller et al, 1994), exclusion of patients who
were never hospitalized with obesity did not affect the risk esti-
mates. These findings suggest that obesity is unlikely to account
for the entire excesses of these tumours in our cohort.
A few methodological issues should be considered in inter-
preting findings from our registry-based cohort study. Reporting of
cancers diagnosed among Danish residents and follow-up of cohort
members for death and emigration are nearly complete (Storm et al,
1992), thus minimizing selection bias. In Denmark, nearly all diag-
noses of gallstones are verified by radiography or ultrasonography,
so that misclassification of non-cases into the cohort is unlikely.
However, a substantial proportion of individuals with gallstones
may remain undiagnosed. To the extent that patients hospitalized
for gallstones may have risk patterns that differ from those of indi-
viduals with ￿silent￿ stones or mild symptoms not requiring hospi-
talization, our findings are not generalizable to non-hospitalized
patients. Furthermore, if a substantial proportion of the general
population has undiagnosed gallstones which predispose to cancer,
then risks in our cohort may be underestimated. On the other hand,
it is possible that cholecystectomies were sometimes carried out on
account of the early symptoms of biliary tract cancers which had
been erroneously attributed to the gallstones that were present. This
may have contributed to the excess of certain biliary tract cancers,
at least in the early period. To minimize bias due to diagnosis of
prevalent cancers, we excluded the person—years and cancers
occurring during the first year of follow-up. Although some of the
significant results in our study might have occurred by chance
because of multiple comparisons, the consistency of the risk
patterns within our dataset and with results of the Swedish study
supports the validity of our findings.
Information on potential confounding factors such as cigarette
smoking and alcohol drinking was not available for adjustment. In
our cohort, however, there was no excess risk for cancers that are
strongly linked to use of tobacco or alcohol, such as lung cancer
(SIR = 1.0, 95% CI = 0.9—1.1) and cancers of the buccal cavity and
pharynx (SIR = 1.1, 95% CI = 0.9—1.4), suggesting that these risk
factors are unlikely to have influenced our findings. It should be
noted that the results for patients with and without cholecystec-
tomy may not be directly comparable, as the non-surgical patients
were much older and likely to have other medical conditions that
precluded surgery.
In conclusion, patients hospitalized for gallstones had an
elevated risk of subsequent cancers of the liver, biliary tract and
pancreas. Treatment with cholecystectomy was associated with a
reduction in the long-term risk for cancers of liver and extrahepatic
bile ducts, but not for cancers of ampulla of Vater and pancreas.
Further research is needed to clarify the carcinogenic risks associ-
ated with gallstones and cholecystectomy and to define the mecha-
nisms involved.
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